Table 5:

Clinical outcomes at 6 months and last follow-up after ETVa

ImprovedSame as BaselineWorse Compared with BaselineP Value
NICO Myriad UsedNo NICO MyriadNICO Myriad UsedNo NICO MyriadNICO Myriad UsedNo NICO Myriad
Headache
    6 Mo88.9%80%11.1%13.3%0%6.7%>.05
    LFU77.8%53.3%22.2%33.3%0%13.3%>.05
Dizziness
    6 Mo100%83.3%0%16.7%0%0%>.05
    LFU100%83.3%0%16.7%0%0%>.05
Nausea
    6 Mo75%75%25%25%0%0%>.05
    LFU50%75%50%25%0%0%>.05
Vision deficit
    6 Mo83.3%77.8%16.7%22.2%0%0%>.05
    LFU83.3%77.8%16.7%22.2%0%0%>.05
Gait abnormality
    6 Mo100%100%0%0%0%0%>.05
    LFU100%70%0%10%0%20%>.05
Urinary incontinence
    6 Mo100%100%0%0%0%0%>.05
    LFU85.7%85.7%0%0%14.3%14.3%>.05
Cognitive dysfunction
    6 Mo87.5%70%12.5%30%0%0%>.05
    LFU87.5%70%12.5%20%0%10%>.05

  • Note:—LFU indicates last follow-up.

  • ↵a Outcomes are given among those with preoperative symptoms.